Lenoss Medical’s OsteoPearl procedure reached its 150th case, according to a March 27 news release shared with Becker’s.
More than half of the 150 cases were completed since September. OsteoPearl is an allograft designed to augment vertebral compression fractures. It provides a natural bone scaffold.
In 2024, Lenoss Medical closed $4 million in series A financing, and that money was used to accelerate commercialization.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
